Legend Biotech (LEGN) Return on Assets: 2020-2025
Historic Return on Assets for Legend Biotech (LEGN) over the last 4 years, with Sep 2025 value amounting to -0.14%.
- Legend Biotech's Return on Assets rose 5.00% to -0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.14%, marking a year-over-year increase of 5.00%. This contributed to the annual value of -0.10% for FY2024, which is 23.00% up from last year.
- Legend Biotech's Return on Assets amounted to -0.14% in Q3 2025, which was up 26.46% from -0.19% recorded in Q2 2025.
- Legend Biotech's Return on Assets' 5-year high stood at -0.02% during Q3 2023, with a 5-year trough of -0.72% in Q1 2021.
- In the last 3 years, Legend Biotech's Return on Assets had a median value of -0.19% in 2024 and averaged -0.20%.
- As far as peak fluctuations go, Legend Biotech's Return on Assets spiked by 41,789bps in 2021, and later decreased by 17bps in 2024.
- Legend Biotech's Return on Assets (Quarterly) stood at -0.31% in 2021, then skyrocketed by 41bps to -0.31% in 2022, then declined by 11bps to -0.28% in 2023, then rose by 18bps to -0.10% in 2024, then rose by 5bps to -0.14% in 2025.
- Its last three reported values are -0.14% in Q3 2025, -0.19% for Q2 2025, and -0.13% during Q1 2025.